Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry.

about

In vivo toxicologic study of larger silica nanoparticles in mice.Platelet microaggregation in sepsis examined by quartz crystal microbalance with dissipation technology.The Role of Mucin in the Toxicological Impact of Polystyrene Nanoparticles.

P2860

Q33638113-B115971D-B117-4DAD-B57E-7857AC57D1AF Q47233068-60BBE138-1CFB-48EC-8FAD-F9AB109DAAA0 Q55011796-89F455DC-2043-41AA-B17C-D9DC30BDBB8D

P2860

Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry.

Item

http://www.wikidata.org/entity/Q40597413

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pharmacological characterizati ...... rison with light aggregometry.

@en

type

Item

label

Pharmacological characterizati ...... rison with light aggregometry.

@en

prefLabel

Pharmacological characterizati ...... rison with light aggregometry.

@en

P1476

Pharmacological characterizati ...... rison with light aggregometry.

@en

P2093

Carlos Medina

http://www.w3.org/2001/XMLSchema#string

Despina Bazou

http://www.w3.org/2001/XMLSchema#string

John F Gilmer

http://www.w3.org/2001/XMLSchema#string

Marek W Radomski

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Nanoparticles: pharmacological and toxicological significance

Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide

Nanoparticle-induced platelet aggregation and vascular thrombosis

A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

Passage of inhaled particles into the blood circulation in humans

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease.

P304

5107-5119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S84305

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Krzysztof A Tomaszewski

Maria J Santos-Martinez

P577

2015-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281204300

http://www.w3.org/2001/XMLSchema#string

P698

26316743

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

P932

4540170

http://www.w3.org/2001/XMLSchema#string

Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry.

about

P2860

P2860

Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P921

P932